CVRXCVRx, Inc.
Surgical & Medical Instruments & Apparatus
- Revenue
- $57M
- 10% YoY
- Operating margin
- -90.5%
- 22% YoY
- EBITDA
- −$51M
- 14% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- −$48M net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCFired20% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear—Over 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $13M | $22M | $39M | $51M | $57M | 10% |
| Operating income | −$26M | −$43M | −$43M | −$59M | −$51M | 14% |
| Net income | −$43M | −$41M | −$41M | −$60M | −$53M | 11% |
| Operating cash flow | −$28M | −$43M | −$39M | −$39M | −$40M | 2.6% |
| Capex | $1M | $685K | $591K | $1M | $580K | 57% |
| Stock-based comp | $2M | $4M | $6M | $19M | $11M | 42% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
No pay-versus-performance disclosure yet.